title: Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study.
abstract: BACKGROUND
  Trichotillomania is characterized by repetitive pulling causing noticeable hair loss. Pharmacological treatment data for trichotillomania are limited.
  
  
  OBJECTIVE
  Dronabinol appears to reduce the exocitotoxic damage caused by glutamate release in the striatum and offers promise in reducing compulsive behavior.
  
  
  METHODS
  Fourteen female subjects (mean age = 33.3  ±  8.9) with DSM-IV trichotillomania were enrolled in a 12-week open-label treatment study of dronabinol (dose ranging from 2.5-15 mg/day). The primary outcome measure was change from baseline to study endpoint on the Massachusetts General Hospital Hair Pulling Scale (MGH-HPS). In order to evaluate effects on cognition, subjects underwent pre- and post-treatment assessments using objective computerized neurocognitive tests. Data were collected from November 2009 to December 2010.
  
  
  RESULTS
  Twelve of the 14 subjects (85.7%) completed the 12-week study. MGH-HPS scores decreased from a mean of 16.5  ±  4.4 at baseline to 8.7  ±  5.5 at study endpoint (p = 0.001). Nine (64.3%) subjects were "responders" (i.e., ≥ 35% reduction on the MGH-HPS and "much or very much improved" Clinical Global Impression scale). The mean effective dose was 11.6  ±  4.1 mg/day. The medication was well-tolerated, with no significant deleterious effects on cognition.
  
  
  CONCLUSIONS
  This study, the first to examine a cannabinoid agonist in the treatment of trichotillomania, found that dronabinol demonstrated statistically significant reductions in trichotillomania symptoms, in the absence of negative cognitive effects. Pharmacological modulation of the cannabinoid system may prove useful in controlling a range of compulsive behaviors. Given the small sample and open-label design, however larger placebo-controlled studies incorporating cognitive measures are warranted.
authors: Department of Psychiatry, University of Minnesota School of Medicine, 2450 Riverside Avenue, Minneapolis, MN 55454, USA. grant045@umn.edu
authors: Jon E
authors: JE
authors: Grant
authors: Brian L
authors: BL
authors: Odlaug
authors: Samuel R
authors: SR
authors: Chamberlain
authors: Suck Won
authors: SW
authors: Kim
references: Am J Psychiatry. 1995 Aug;152(8):1192-6
references: 7625469
references: Psychopharmacol Bull. 1992;28(2):145-9
references: 1513916
references: J Psychoactive Drugs. 1998 Apr-Jun;30(2):187-96
references: 9692381
references: Am J Med Genet B Neuropsychiatr Genet. 2009 Jul 5;150B(5):710-20
references: 19051237
references: J Clin Psychiatry. 2006 Jul;67(7):1086-92
references: 16889452
references: Philos Trans R Soc Lond B Biol Sci. 2010 Jan 27;365(1538):319-30
references: 20026469
references: Nat Neurosci. 2002 May;5(5):446-51
references: 11976704
references: Science. 2003 Oct 3;302(5642):84-8
references: 14526074
references: Eur Arch Psychiatry Clin Neurosci. 1997;247(4):234-6
references: 9332906
references: Behav Res Ther. 1994 Jul;32(6):651-62
references: 8085996
references: J Clin Psychiatry. 1992 Sep;53(9):304-8
references: 1517191
references: N Engl J Med. 1989 Aug 24;321(8):497-501
references: 2761586
references: Int Clin Psychopharmacol. 2007 Jan;22(1):39-42
references: 17159458
references: Arch Gen Psychiatry. 2009 Jul;66(7):756-63
references: 19581567
references: Neurosci Lett. 1992 Dec 14;148(1-2):173-6
references: 1300492
references: Schizophr Res. 2011 May;128(1-3):111-6
references: 21420282
references: J Neurosci. 2007 Feb 28;27(9):2396-402
references: 17329437
references: Psychopharmacology (Berl). 2006 Nov;188(4):425-44
references: 17019571
references: Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6
references: 2308954
references: Depress Anxiety. 2011 Apr;28(4):310-3
references: 21456040
references: J Clin Psychiatry. 2006 Dec;67(12):1877-88
references: 17194265
references: Behav Ther. 2006 Dec;37(4):353-63
references: 17071213
references: J Clin Psychiatry. 2010 Oct;71(10):1336-43
references: 20441724
references: Trends Cogn Sci. 2004 Apr;8(4):170-7
references: 15050513
references: Brain. 2002 Mar;125(Pt 3):624-39
references: 11872618
references: Arch Gen Psychiatry. 2010 Sep;67(9):965-71
references: 20819990
references: Drug Alcohol Depend. 2006 Nov 8;85(2):114-22
references: 16723194
references: Behav Res Ther. 2006 May;44(5):639-56
references: 16039603
references: J Pain Symptom Manage. 1995 Feb;10(2):89-97
references: 7730690
references: Brain. 2008 May;131(Pt 5):1311-22
references: 18390562
references: Pharmacopsychiatry. 2002 Mar;35(2):57-61
references: 11951146
references: J Psychopharmacol. 2009 May;23(3):266-77
references: 18719045
references: Psychother Psychosom. 1995;64(3-4):141-5
references: 8657844
references: Am J Psychiatry. 1991 Nov;148(11):1566-71
references: 1928474
references: J Neurosci. 1997 Jul 15;17(14):5327-33
references: 9204917
references: Psychol Med. 2009 Oct;39(10):1607-16
references: 19335936
references: Curr Drug Abuse Rev. 2008 Jun;1(2):114-23
references: 19630711
references: J Exp Psychol Hum Percept Perform. 1984 Apr;10(2):276-91
references: 6232345
references: Neuromolecular Med. 2005;7(1-2):37-50
references: 16052037
references: J Neurosci. 2008 Jul 16;28(29):7284-92
references: 18632932
references: J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
references: 14399272
references: J Psychopharmacol. 2011 Apr;25(4):478-89
references: 20817749
references: Eur J Neurosci. 2004 Apr;19(7):1691-8
references: 15078543
references: Psychopharmacology (Berl). 2009 May;204(1):85-94
references: 19099294
references: Acta Psychiatr Scand. 1998 Dec;98(6):502-6
references: 9879795
references: Cogn Behav Ther. 2007;36(3):129-44
references: 17852170
references: J Neurosci. 2010 Jun 16;30(24):8127-37
references: 20554863
references: J Pain Symptom Manage. 1997 Jul;14(1):7-14
references: 9223837
references: Biol Psychiatry. 2011 Jun 15;69(12):1192-203
references: 21047621
references: Psychopharmacol Bull. 1998;34(2):221-4
references: 9641004
references: Br J Med Psychol. 1959;32(1):50-5
references: 13638508
references: Brain. 1996 Oct;119 ( Pt 5):1597-615
references: 8931583
references: Pharmacol Res. 2009 Aug;60(2):132-8
references: 19559364
references: N Engl J Med. 1993 Jul 8;329(2):141-2
references: 8510704
references: Am J Psychiatry. 1991 Mar;148(3):365-70
references: 1992841
references: J Psychosom Res. 2007 Jun;62(6):707-9
references: 17540230
references: Curr Opin Psychiatry. 2007 May;20(3):255-61
references: 17415079
references: J Anxiety Disord. 2010 Dec;24(8):823-9
references: 20594805